Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by M&G Plc

M&G Plc boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 53.5% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 5,069 shares of the medical equipment provider’s stock after purchasing an additional 1,766 shares during the period. M&G Plc’s holdings in Intuitive Surgical were worth $2,256,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Indiana Trust & Investment Management CO increased its position in Intuitive Surgical by 5.3% during the 2nd quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock worth $222,000 after purchasing an additional 25 shares in the last quarter. First Affirmative Financial Network grew its holdings in shares of Intuitive Surgical by 2.7% during the second quarter. First Affirmative Financial Network now owns 996 shares of the medical equipment provider’s stock worth $443,000 after buying an additional 26 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its position in shares of Intuitive Surgical by 0.3% in the fourth quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider’s stock valued at $3,002,000 after buying an additional 27 shares during the last quarter. Advance Capital Management Inc. lifted its stake in shares of Intuitive Surgical by 3.8% during the first quarter. Advance Capital Management Inc. now owns 740 shares of the medical equipment provider’s stock valued at $295,000 after buying an additional 27 shares during the period. Finally, Perigon Wealth Management LLC boosted its position in Intuitive Surgical by 0.5% during the first quarter. Perigon Wealth Management LLC now owns 5,363 shares of the medical equipment provider’s stock worth $2,140,000 after acquiring an additional 27 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at $5,441,507.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares in the company, valued at $5,441,507.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,558,968.56. The disclosure for this sale can be found here. Insiders sold 15,547 shares of company stock valued at $6,735,194 in the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Up 0.8 %

Shares of ISRG traded up $3.70 during trading hours on Tuesday, hitting $469.23. The company had a trading volume of 884,791 shares, compared to its average volume of 1,561,007. The business has a fifty day moving average of $438.40 and a 200-day moving average of $405.13. The firm has a market cap of $166.44 billion, a price-to-earnings ratio of 84.43, a PEG ratio of 4.97 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $470.49.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.18 earnings per share. On average, equities analysts expect that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research analyst reports. JPMorgan Chase & Co. upped their price objective on shares of Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 19th. Evercore ISI cut their price target on shares of Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a research note on Friday, July 19th. Morgan Stanley boosted their price target on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a report on Friday, April 19th. Finally, Citigroup lifted their price objective on shares of Intuitive Surgical from $462.00 to $512.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $442.30.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.